Essity to Buy Back Shares

Essity's Board of Directors has resolved to utilize the authorization granted by the Annual General Meeting on March 21, 2024, and initiate a program to buy back Class B shares in Essity for SEK 3bn.

Essity’s board of directors have resolved to utilize the authorization granted by the Annual General Meeting on March 21, 2024, and initiate a program to buy back Class B shares in Essity for SEK 3bn, but not exceeding 10 percent of the total number of shares outstanding. The buyback program begins on June 17, 2024, and extends until the 2025 Annual General Meeting. The repurchased shares are expected to be canceled. The share repurchase will be financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buy backs over time as a recurring part of Essity’s capital allocation.

The share buyback program will be managed by Danske Bank, which will decide on the date for repurchasing independently from and outside of Essity’s influence. Repurchasing will take place on Nasdaq Stockholm in accordance with the stock exchange’s issuer regulations and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation).

Otherwise, the following terms and conditions apply to the share buyback program:

The shares are to be acquired at a price per share within the band of prices prevailing at any given time on Nasdaq Stockholm, which refers to the range between the highest purchase price and lowest selling price prevailing and disseminated by Nasdaq Stockholm.

The shares will be paid for in cash.

The total number of Essity shares is 702,342,489, of which 60,969,986 Class A shares and 641,372,503 Class B shares. Essity currently holds no shares in treasury.

Back to Tissue360 Newsletter